[1]彭艳红,蒋亦昕,白光,等.胃炎康方对慢性非萎缩性胃炎患者胃泌素相关基因调控通路影响[J].中国中医药信息杂志,2019,26(2):42-46.[doi:10.3969/j.issn.1005-5304.2019.02.010]
 PENG Yanhong,JIANG Yixin,BAI Guang,et al.Effect of Weiyankang Prescription on Gastrin-related Gene Regulation Pathway of Chronic Non-atrophic Gastritis[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):42-46.[doi:10.3969/j.issn.1005-5304.2019.02.010]
点击复制

胃炎康方对慢性非萎缩性胃炎患者胃泌素相关基因调控通路影响

参考文献/References:

[1] 奚锦要,朱永钦,朱永苹,等.中药复方辨证论治慢性萎缩性胃炎的临床研究进展[J].时珍国医国药,2016,27(12):2978-2980.
[2] 郭昱,郭霞,姚希贤.慢性萎缩性胃炎胃泌素、生长抑素、表皮生长因子、血管活性肠肽的测定及临床意义[J].世界华人消化杂志,2003, 11(5):531-534.
[3] 何甜,唐慧,郭强,等.趋化因子10在慢性非萎缩性胃炎、胃癌癌前病变及胃癌中的表达及意义[J].重庆医学,2014,43(4):388-390.
[4] 黄懋敏,董丹丹,亓丹丹,等.慢性萎缩性胃炎患者Hp感染与TGF-βRⅡ、IL-6和TNF-α的表达研究[J].中国免疫学杂志,2018,34(5):751-756.
[5] 林志强,王大璇,洪珊珊,等.香砂六君子汤对菌致慢性萎缩性胃炎TLR信号通路的影响[J].中国中药杂志,2016,41(16):3078-3083.
[6] 中华医学会消化病学分会.中国慢性胃炎共识意见(2017年,上海)[J].中华消化杂志,2017,37(11):721-738.
[7] 中华医学会消化内镜学分会.慢性胃炎的内镜分型分级标准及治疗的试行意见[J].中华消化内镜杂志,2004,21(2):77-78.
[8] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
[9] CUI M, YU W, DONG J, et al. Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma[J]. Med Oncol,2010,27(3):632-639.
[10] 崔梅花,张欣焱,乙国兴,等.酿酒酵母菌抗原在炎症性肠病结肠组织中的表达及意义[J].中华临床医师杂志(电子版),2011,5(4):986-989.
[11] 乔世峰,王季堃,李世正,等.PIK3CD基因沉默可抑制胃癌HGC-27细胞的体外增殖和迁移[J].肿瘤,2015,35(1):24-30.
[12] 陈国胜.胃泌素/CCK2R通过JAK2/STAT3通路上调COX-2表达诱导胃癌细胞增殖[D].南京:南京医科大学,2015.
[13] 张利红,程静静,夏和先,等.幽门螺杆菌感染与慢性胃炎和胃癌的致病机制研究进展[J].国际检验医学杂志,2016,37(22):3165-3167.
[14] CAO X, TSUKAMOTO T, NOZAKI K, et al. Severity of gastritis determines glandular stomach carcinogenesis in helicobacter pylori-infected mongolian gerbils[J]. Cancer Sci,2007,98(4):478-483.
[15] 喻德林,胡希亚.幽门螺杆菌根除性治疗对慢性胃炎患者胃泌素及细胞因子的影响[J].现代消化及介入诊疗,2016,21(4):619-622.
[16] SAUKKONEN K, RINTAHAKA J, SIVULA A, et al. Cyclooxygenase-2 and gastric carcinogenesis[J]. APMIS,2003,111(10):915-925.
[17] WANG Q S, XIANG Y, CUI Y L, et al. Dietary blue pigments derived from genipin, attenuate inflammation by inhibiting LPS-induced iNOS and COX-2 expression via the NF-κB inactivation[J]. PLoS One, 2012,7(3):e34122.
[18] 陈文标,杨维群,刘立飞,等.胃癌组织中Keap1、IKKβ蛋白表达及意义[J].胃肠病学和肝病学杂志,2016,25(6):638-641.
[19] VELLA V, NICOLOSI M L, GIULIANO S, et al. PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis[J]. Front Endocrinol (Lausanne),2017,8:31.
[20] 王雷,蔡冰.PIK3CD表达量检测对胃癌临床病理分期及恶性程度的评估价值[J].海南医学院学报,2016,22(9):924-927.
[21] 乔世峰,李世正,佟鑫.PIK3CD表达上调与胃癌临床病理特征及患者预后的相关性[J].中国肿瘤生物治疗杂志,2015,22(1):62-66.
[22] BR?CHER B L, LI Y, SCHNABEL P, et al. Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers[J]. Clin Transl Med,2016, 5(1):13.
[23] OLMAN M A. Beyond TGF-beta:a prostaglandin promotes fibrosis[J]. Nat Med,2009,15(12):1360-1361.
[24] 李常恩,姚英民,韩少山,等.胆管良性瘢痕组织中前列腺素F2α受体及前列腺素合酶2的表达及意义[J].中国普外基础与临床杂志,2011, 18(12):1283-1287.

相似文献/References:

[1]张贵彪,陈启龙,苏式兵?.中药网络药理学研究进展[J].中国中医药信息杂志,2013,20(8):103.[doi:10.3969/j.issn.1005-5304.2013.08.049]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(2):103.[doi:10.3969/j.issn.1005-5304.2013.08.049]
[2]李从林,王博龙.基于网络药理学的益母草作用机制分析[J].中国中医药信息杂志,2018,25(12):102.[doi:10.3969/j.issn.1005-5304.2018.12.024]
 LI Cong-lin,WANG Bo-long.Analysis on Mechanism of Effects of Leonu ri Herba Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2018,25(2):102.[doi:10.3969/j.issn.1005-5304.2018.12.024]
[3]严卿莹,叶晔,冯冠,等.基于网络药理学的虎杖治疗结直肠癌作用机制研究[J].中国中医药信息杂志,2019,26(4):96.[doi:10.3969/j.issn.1005-5304.2019.04.020]
 YAN Qingying,YE Ye,FENG Guan,et al.Study on Mechanism of Polygoni Cuspidati Rhizoma et Radix in Treatment of Colorectal Cancer Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):96.[doi:10.3969/j.issn.1005-5304.2019.04.020]
[4]李康宁,王蕾,于佳佳,等.基于网络药理学的补肾益髓胶囊治疗多发性硬化机制研究[J].中国中医药信息杂志,2019,26(5):98.[doi:10.3969/j.issn.1005-5304.2019.05.021]
 LI Kangning,WANG Lei,YU Jiajia,et al.Mechanism Study on Bushen Yisui Capsules for Treatment of Multiple Sclerosis Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):98.[doi:10.3969/j.issn.1005-5304.2019.05.021]
[5]李金霞,指导:曹洪欣.基于复杂网络的温心方治疗冠状动脉狭窄机制研究[J].中国中医药信息杂志,2019,26(6):101.[doi:10.3969/j.issn.1005-5304.2019.06.021]
 LI Jinxia,Instructor: CAO Hongxin.Study on Mechanism of Wenxin Decoction in Treating Coronary Artery Stenosis Based on Complex Network[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):101.[doi:10.3969/j.issn.1005-5304.2019.06.021]
[6]唐标,唐文静,邓常清.基于网络药理学的黄芪和三七主要有效成分配伍抗缺血性脑损伤作用机制研究[J].中国中医药信息杂志,2019,26(7):109.[doi:10.3969/j.issn.1005-5304.2019.07.024]
 TANG Biao,TANG Wenjing,DENG Changqing.Study on Mechanism of Compatibility of Main Active Components of Astragali Radix and Notoginseng Radix et Rhizoma on Cerebral Ischemic Injury Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):109.[doi:10.3969/j.issn.1005-5304.2019.07.024]
[7]赵文文,贾占波,王庆峰,等.脐灸疗法对溃疡性结肠炎患者BTNL2-HLA信号通路影响机制的生物信息学研究[J].中国中医药信息杂志,2019,26(8):18.[doi:10.3969/j.issn.1005-5304.2019.08.005]
 ZHAO Wenwen,JIA Zhanbo,WANG Qingfeng,et al.Bioinformatic Study on Mechanism of Umbilical Moxibustion on BTNL2-HLA Signaling Pathway in Patients with Ulcerative Colitis[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):18.[doi:10.3969/j.issn.1005-5304.2019.08.005]
[8]刘云娣,高佳珠,杨智华,等.基于网络药理学的补肾益心片治疗高血压分子机制研究[J].中国中医药信息杂志,2019,26(8):104.[doi:10.3969/j.issn.1005-5304.2019.08.021]
 LIU Yundi,GAO Jiazhu,YANG Zhihua,et al.Study on Molecules Mechanism of Bushen Yixin Tablets for Hypertension Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):104.[doi:10.3969/j.issn.1005-5304.2019.08.021]

备注/Memo

基金项目:沈阳市科技计划项目(18-013-0-44);北京市医学科学研究基金(A220);辽宁省自然科学基金(20170540609);国家中医药管理局第三届国医大师传承工作室及全国名中医传承工作室建设项目(2018年)
通讯作者:白光,E-mail:lnzyxhk@126.com

更新日期/Last Update:

2019-02-15